Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.7031
-0.0423 (-5.67%)
At close: Oct 17, 2025, 4:00 PM EDT
0.6054
-0.0977 (-13.90%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Femasys Market Cap
Femasys has a market cap or net worth of $30.24 million as of October 17, 2025. Its market cap has increased by 19.31% in one year.
Market Cap
30.24M
Enterprise Value
34.87M
1-Year Change
19.31%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $30.24M, a decrease of -80.22%. That is a compound annual growth rate of -31.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 30.24M | 20.06% |
| Dec 31, 2024 | 25.19M | 19.33% |
| Dec 29, 2023 | 21.11M | 98.53% |
| Dec 30, 2022 | 10.63M | -76.90% |
| Dec 31, 2021 | 46.02M | -69.90% |
| Jun 18, 2021 | 152.90M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |